Angiotensin 2 Receptor Blocker [EPC]

238185 reported adverse events

Drugs of this class: VALSARTAN VALSARTAN AND HYDROCHLOROTHIAZIDE IRBESARTAN TELMISARTAN IRBESARTAN AND HYDROCHLOROTHIAZIDE TELMISARTAN AND HYDROCHLOROTHIAZIDE AMLODIPINE AND VALSARTAN TELMISARTAN AND AMLODIPINE AMLODIPINE BESYLATE AND VALSARTAN AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE

These side effects are most commonly reported by patients taking drugs of the Angiotensin 2 Receptor Blocker [EPC] class:

# Side effect Count
0 DYSPNOEA 14390
1 DIZZINESS 14339
2 FATIGUE 13743
3 HYPOTENSION 12211
4 DRUG INEFFECTIVE 10978
5 DEATH 10897
6 NAUSEA 9588
7 MALAISE 9357
8 COUGH 8831
9 DIARRHOEA 8749
See all common reactions for Angiotensin 2 Receptor Blocker [EPC]

Drugs of the Angiotensin 2 Receptor Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THROAT CLEARING 740 0.4545
1 EJECTION FRACTION ABNORMAL 316 0.3873
2 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 186 0.2605
3 BLOOD PRESSURE INADEQUATELY CONTROLLED 1345 0.2489
4 CAROTID ARTERY THROMBOSIS 124 0.2250
5 CARDIAC FAILURE CHRONIC 549 0.2031
6 CARDIAC DYSFUNCTION 291 0.1671
7 EJECTION FRACTION DECREASED 1868 0.1657
8 ADJUSTMENT DISORDER 132 0.1435
9 NEPHROGENIC ANAEMIA 589 0.1418
See all enriched reactions for Angiotensin 2 Receptor Blocker [EPC]